GlassScriptPhysician profile
Jon D Green
NPI 1245283563
$2,784.25
in general payments reported to CMS, 2019-2025
24 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $791 · 2020: $289 · 2021: $383 · 2022: $292 · 2023: $406 · 2024: $274 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $639.53 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $457.91 | 2019-2023 | Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $286.99 | 2019-2025 | Entyvio, Gattex |
| Janssen Biotech, INC. | $268.11 | 2024-2025 | Tremfya |
| Celgene Corporation | $209.02 | 2021-2024 | Zeposia |
| Nestle Healthcare Nutrition INC. | $117.15 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $115.88 | 2019-2023 | Rebyota |
| E.R. Squibb & Sons, L.L.C. | $113.96 | 2023 | |
| Merck Sharp & Dohme LLC | $73.30 | 2019-2021 | |
| Redhill Biopharma INC. | $70.64 | 2020-2023 | |
| Aimmune Therapeutics, INC. | $63.43 | 2024-2025 | Zenpep |
| Braintree Laboratories, INC. | $61.43 | 2019-2022 | |
| Pfizer INC. | $55.26 | 2024-2025 | |
| Boston Scientific Corporation | $43.18 | 2019 | |
| Amgen INC. | $28.92 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $27.14 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.90 | 2019-2020 | |
| Gilead Sciences, INC. | $24.01 | 2019-2020 | |
| Olympus America INC. | $22.18 | 2024 | Evis X1 Video System Center |
| Dexcom, INC. | $22.04 | 2025 | Dexcom G6 Transmitter |
| Intercept Pharmaceuticals, INC. | $15.00 | 2020 | |
| Biotronik Nro, INC. | $14.75 | 2025 | Prospera |
| Ironwood Pharmaceuticals, INC | $14.39 | 2019 | |
| Allergan, INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.